A second pathway into cells for SARS‑CoV‑2: New understanding of the neuropilin‑1 protein could speed vaccine research
Scientists in the UK and Germany discovered a new doorway that the COVID-19 virus uses to infect human cells. This reveals new therapeutic possibilities for blocking the virus.